BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15168788)

  • 1. Transdermal drug delivery systems of a beta blocker: design, in vitro, and in vivo characterization.
    Aqil M; Sultana Y; Ali A; Dubey K; Najmi AK; Pillai KK
    Drug Deliv; 2004; 11(1):27-31. PubMed ID: 15168788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix type transdermal drug delivery systems of metoprolol tartrate: in vitro characterization.
    Aqil M; Sultana Y; Ali A
    Acta Pharm; 2003 Jun; 53(2):119-25. PubMed ID: 14764246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system.
    Malipeddi VR; Awasthi R; Ghisleni DD; de Souza Braga M; Kikuchi IS; de Jesus Andreoli Pinto T; Dua K
    Drug Deliv Transl Res; 2017 Feb; 7(1):66-76. PubMed ID: 27677866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo assessment of matrix type transdermal therapeutic system of labetalol hydrochloride.
    Mittal A; Parmar S; Singh B
    Curr Drug Deliv; 2009 Oct; 6(5):511-9. PubMed ID: 19863491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: in vitro characterisation.
    Aqil M; Ali A
    Eur J Pharm Biopharm; 2002 Sep; 54(2):161-4. PubMed ID: 12191687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and in-vitro evaluation of transdermal matrix films of metoprolol tartrate.
    Bhatt DC; Dhake AS; Khar RK; Mishra DN
    Yakugaku Zasshi; 2008 Sep; 128(9):1325-31. PubMed ID: 18758147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of nitrendipine transdermal patches: in vitro and ex vivo characterization.
    Gannu R; Vishnu YV; Kishan V; Rao YM
    Curr Drug Deliv; 2007 Jan; 4(1):69-76. PubMed ID: 17269919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, development, physicochemical, in vitro and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine.
    Mittal A; Sara US; Ali A; Mohammed A
    Pharm Dev Technol; 2009; 14(4):422-34. PubMed ID: 19630699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication and evaluation of polymeric films for transdermal delivery of pinacidil.
    Aqil M; Ali A; Sultana Y; Najmi AK
    Pharmazie; 2004 Aug; 59(8):631-5. PubMed ID: 15378854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal therapeutic system of isradipine: effect of hydrophilic and hydrophobic matrix on in vitro and ex vivo characteristics.
    Tirunagari M; Jangala VR; Khagga M; Gannu R
    Arch Pharm Res; 2010 Jul; 33(7):1025-33. PubMed ID: 20661712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PREPARATION, IN VITRO AND IN VIVO CHARACTERIZATION OF HYDROPHOBIC PATCHES OF A HIGHLY WATER SOLUBLE DRUG FOR PROLONGED PLASMA HALF LIFE: EFFECT OF PERMEATION ENHANCERS.
    Yaqoob A; Ahmad M; Mahmood A; Sarfraz RM
    Acta Pol Pharm; 2016 Nov; 73(6):1639-1648. PubMed ID: 29634120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation design and in vitro ex vivo evaluation of transdermal patches of Cinnarizine.
    Yamsani VV; Mudulaghar MK; Afreen S; Wajid S; Ravula SK; Babelghaith SD
    Pak J Pharm Sci; 2017 Nov; 30(6):2075-2083. PubMed ID: 29175776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use.
    Amnuaikit C; Ikeuchi I; Ogawara K; Higaki K; Kimura T
    Int J Pharm; 2005 Jan; 289(1-2):167-78. PubMed ID: 15652209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin.
    Babu RJ; Pandit JK
    Drug Deliv; 2005; 12(3):165-9. PubMed ID: 16025846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
    Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
    Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal drug delivery of labetolol hydrochloride: system development, in vitro; ex vivo and in vivo characterization.
    Aqil M; Zafar S; Ali A; Ahmad S
    Curr Drug Deliv; 2005 Apr; 2(2):125-31. PubMed ID: 16305413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of carvedilol transdermal patches: evaluation of physicochemical, ex vivo and mechanical properties.
    Gannu R; Vishnu YV; Kishan V; Rao YM
    PDA J Pharm Sci Technol; 2008; 62(6):391-401. PubMed ID: 19634343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and Evaluation of Transdermal Patches of Timolol Maleate.
    Panchayya Hiremath SS; Reddy JJ; Jamakandi VG
    Curr Drug Deliv; 2018; 15(5):658-663. PubMed ID: 28969565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo transdermal studies of atenolol using iontophoresis.
    Inal O; Kiliçarslan M; Ari N; Baykara T
    Acta Pol Pharm; 2008; 65(1):29-36. PubMed ID: 18536170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies.
    Panchagnula R; Bokalial R; Sharma P; Khandavilli S
    Int J Pharm; 2005 Apr; 293(1-2):213-23. PubMed ID: 15778059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.